MMP2 and central nervous system cancer: Current research has shown that glioma cells frequently activate the perk arm of the UPR by increasing the levels of the metalloproteinases (MMPs) MMP2 and MMP7, which promote the epithelial-mesenchymal transition (EMT) (29, 30).